Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuehong Zhu
Institutions:
Zhejiang Chinese Medical University,
Huzhou Normal University,
Huzhou Central Hospital
Observed institutions:
Zhejiang Chinese Medical University,
Nankai University,
Tianjin Medical University Cancer Institute and Hospital,
Huzhou Normal University,
Huzhou Central Hospital,
Zhejiang Hospital,
First Affiliated Hospital of Wannan Medical College,
Tianjin Medical University
show all 8
ORCID:
0000-0002-0971-5577
Observed ORCID:
0000-0002-0971-5577
OpenAlex ID:
A5103269372
The microprotein encoded by exosomal lncAKR1C2 promotes gastric cancer lymph node metastasis by regulating fatty acid metabolism
2023
·
Ke-Gan Zhu
, Jiayu Yang
, et al.
·
Cell Death and Disease
·
64
PDF
p53 in colorectal cancer: from a master player to a privileged therapy target
2025
·
Sicheng Yan
, Fuyuan Zhan
, et al.
·
Journal of Translational Medicine
·
44
PDF
Analysis of Clinical Characteristics, Treatment, and Prognostic Factors of 106 Breast Cancer Patients With Solitary Pulmonary Nodules
2022
·
Lihong He
, Xiaorui Wang
, et al.
·
Frontiers in Surgery
·
28
PDF
Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway
2020
·
Lin Li
, Weimin Lou
, et al.
·
Annals of Vascular Surgery
·
28
Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
2024
·
Sicheng Yan
, Yuxuan He
, et al.
·
Frontiers in Cell and Developmental Biology
·
13
PDF
Integrated Analysis of mRNA–miRNA–lncRNA ceRNA Network in Human HR+/Her-2− Breast Cancer and Triple Negative Breast Cancer
2019
·
Xiaochen Jia
, Yehui Shi
, et al.
·
Journal of Computational Biology
·
11
Glycyrrhizin inhibits the invasion and metastasis of breast cancer cells via upregulation of expressions of miR-200c and e-cadherin
2020
·
Lihong He
, Xiaorui Wang
, et al.
·
Tropical Journal of Pharmaceutical Research
·
7
PDF
Comparative analysis of engineered-exosome delivered si-HER2 and trastuzumab in the treatment of HER2-positive gastric cancer
2025
·
Yuehong Zhu
, Yaoyang Guo
, et al.
·
Investigational New Drugs
·
4
ITGA4 Contributes to 5-Fluorouracil Resistance by Up-Regulating PI3K/AKT Signaling: Evidence from Network Pharmacology, Molecular Docking and Experimental Verification
2025
·
Sicheng Yan
, Xiaomeng Hu
, et al.
·
Drug Design Development and Therapy
·
4
ARNTL2: a key player in promoting tumor aggressiveness in papillary thyroid cancer
2025
·
Qing Zhai
, Han Wu
, et al.
·
Translational Cancer Research
·
4
Ginsenoside induces cell death in breast cancer cells via ROS/PI3K/Akt signaling pathway
2020
·
Lihong He
, Xiaorui Wang
, et al.
·
Tropical Journal of Pharmaceutical Research
·
4
PDF
Exploring the potential mechanisms of Erigeron breviscapus in the treatment of glaucoma based on network pharmacology and molecular docking
2025
·
Enyang Yang
, Yuehong Zhu
, et al.
·
Medicine
·
1
Utidelone in combination with etoposide and bevacizumab in HER2-negative breast cancer patients with brain metastasis: A prospective, single-arm, phase II trial.
2025
·
Yehui Shi
, Peng Wang
, et al.
·
Journal of Clinical Oncology
·
1
Effects of rapamycin and 3-MA on motor behavior and autophagy related protein LC3 in PD model mice
2016
·
You Wu
, Rongbo Zhang
, et al.
·
Zhonghua xingwei yixue yu naokexue zazhi
·
1
Metabolic reprogramming of regulatory T cells: a promising avenue for boosting immunotherapeutic synergy in colorectal cancer
2026
·
Jiang Pei
, Yan Chen
, et al.
·
Journal of Translational Medicine
Crocin protects against smoke-induced chronic obstructive pulmonary disease by regulating AKT1
2026
·
Yuehong Zhu
, Yuntao Jiang
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
16
Citation count:
214
H-index:
7
I10-index:
6
Year
Topic
Type